Studies Showcase Less Invasive, More Equitable Testing for Women’s Cancers
At ADLM 2025, researchers spotlight diagnostic innovations that aim to improve gynecologic cancer detection through greater access and less invasive methods.
At ADLM 2025, researchers spotlight diagnostic innovations that aim to improve gynecologic cancer detection through greater access and less invasive methods.
Blood-based biomarker tests are revolutionizing Alzheimer's diagnostic testing and management of Alzheimer’s disease.
The increasing demand for laboratory tests presents a unique challenge for clinical labs already battling staffing shortages.
In recent years, clinical laboratories have increasingly embraced automation to address challenges such as staffing shortages, budget constraints, and inefficiencies in manual processing.
AI-enhanced EEG technology is emerging as a promising tool for early detection of Alzheimer's disease, potentially facilitating prevention efforts before symptoms appear.